Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

Senior Center Based Hepatitis C Screening in Baltimore

HCV prevalence in our population was an order of magnitude higher than national estimates. This can be in part explained by high rates of IDU in Baltimore City (prevalence of injection drug use of 336/10,000 population aged 15-64).[13] High rates of hepatitis C in those born before 1945 may also partly be explained by introduction of heroin use into Baltimore in the 1950s.

https://www.researchgate.net/publication/290221608_Senior_Center_Based_Hepatitis_C_Screening_in_Baltimore